Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
JNJ | 53.54% | $360.54B | -3.03% | 3.32% |
MMC | 52.71% | $111.97B | +8.65% | 1.43% |
NVS | 52.31% | $205.81B | +5.62% | 3.69% |
WEC | 51.81% | $33.48B | +22.69% | 3.29% |
MDT | 50.54% | $110.44B | +0.55% | 3.26% |
D | 49.32% | $46.94B | +3.26% | 4.86% |
SYK | 48.60% | $149.89B | +17.43% | 0.84% |
SO | 48.02% | $96.04B | +10.08% | 3.29% |
ATO | 47.94% | $24.77B | +31.55% | 2.15% |
PG | 46.92% | $380.78B | -3.25% | 2.51% |
IDA | 46.34% | $6.17B | +15.50% | 2.98% |
ADP | 46.29% | $128.21B | +26.31% | 1.87% |
AFL | 45.84% | $57.19B | +21.39% | 1.97% |
MA | 45.83% | $528.67B | +26.88% | 0.49% |
CL | 45.79% | $72.64B | -5.18% | 2.25% |
DUK | 45.68% | $90.12B | +12.74% | 3.61% |
V | 45.31% | $702.56B | +29.47% | 0.77% |
AEE | 44.93% | $26.17B | +29.27% | 2.81% |
AEP | 44.28% | $54.28B | +9.80% | 3.61% |
OGE | 43.82% | $8.84B | +19.25% | 3.82% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CAMT | -12.92% | $3.03B | -31.88% | 0.00% |
ANF | -12.91% | $3.79B | -41.29% | 0.00% |
MYRG | -12.59% | $2.54B | +7.70% | 0.00% |
HUSA | -12.00% | $9.73M | -55.71% | 0.00% |
TLN | -11.95% | $11.14B | +126.67% | 0.00% |
ROAD | -11.75% | $5.55B | +80.73% | 0.00% |
POAI | -11.67% | $9.82M | -34.52% | 0.00% |
NVT | -11.51% | $11.01B | -16.86% | 1.16% |
MOD | -11.31% | $5.39B | -1.27% | 0.00% |
RDUS | -11.23% | $828.01M | +54.12% | 2.55% |
NVDA | -11.10% | $3.29T | +42.89% | 0.03% |
ALAB | -11.07% | $15.20B | +26.29% | 0.00% |
PWR | -10.91% | $50.44B | +29.02% | 0.11% |
ONTO | -10.57% | $4.79B | -56.23% | 0.00% |
STRL | -10.55% | $5.62B | +42.14% | 0.00% |
AVGO | -10.53% | $1.09T | +64.74% | 3.02% |
SMTC | -10.29% | $3.43B | -0.50% | 0.00% |
ALXO | -9.56% | $23.29M | -97.03% | 0.00% |
TTD | -9.44% | $38.09B | -16.84% | 0.00% |
TSM | -9.41% | $1.01T | +27.58% | 1.26% |
Current Value
$133.141 Year Return
Current Value
$133.141 Year Return
Yahoo
Abbott Laboratories is a dividend stock you can buy and (almost) forget about. AbbVie has proved its resilience by becoming stronger after losing patent exclusivity for its blockbuster drug Humira. Johnson & Johnson is a seasoned dividend payer for all seasons.
Yahoo
Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Yahoo
HIMS is expanding its health and wellness products and services and increasing its focus on AI to solidify its footing. However, macro challenges may hurt performance.
Yahoo
Abbott Laboratories (NYSE:ABT) has recently announced compelling study findings about its FreeStyle Libre® technology, which show a decrease in hospitalization risks for diabetes patients, potentially reducing healthcare costs. This news underscores the positive advancements in the company’s product line. Meanwhile, recent earnings with a reported increase in both sales and net income, alongside reaffirmed growth guidance, reflect a strong financial position. In the broader market, index...
MarketWatch
Abbott Laboratories stock outperforms competitors on strong trading day
Yahoo
Abbott (NYSE: ABT) today announced results from its REFLECT real-world studies that show the use of FreeStyle Libre® continuous glucose monitoring (CGM) technology is associated with a significant reduction in the risk of hospitalization for heart complications in people with diabetes. For the first time, data show that CGM technology can help lessen the severity of cardiovascular complications – regardless of a prior history of low blood sugar events or heart disease-related hospitalizations –
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CNTY | <0.01% | $54.31M | -41.20% | 0.00% |
CRMT | 0.02% | $426.31M | -19.95% | 0.00% |
ALGT | 0.02% | $1.01B | +0.91% | 0.00% |
GLOB | -0.02% | $5.85B | -25.26% | 0.00% |
QNTM | 0.03% | $21.04M | -55.31% | 0.00% |
OKTA | 0.04% | $21.76B | +23.48% | 0.00% |
PLUG | -0.05% | $754.19M | -79.61% | 0.00% |
SNPS | -0.06% | $79.55B | -9.62% | 0.00% |
EH | 0.06% | $999.63M | +0.58% | 0.00% |
SUZ | -0.07% | $11.77B | -2.77% | 0.00% |
CCJ | -0.08% | $22.46B | +3.53% | 0.22% |
MOMO | -0.10% | $768.25M | +8.00% | 0.00% |
MTLS | 0.10% | $307.15M | -0.19% | 0.00% |
RUM | -0.10% | $3.49B | +42.34% | 0.00% |
ASTS | -0.12% | $6.27B | +551.12% | 0.00% |
CYRX | -0.12% | $337.42M | -50.73% | 0.00% |
HUBS | 0.12% | $35.02B | +8.80% | 0.00% |
KLTR | 0.13% | $333.35M | +82.35% | 0.00% |
WEAV | -0.14% | $813.47M | +18.51% | 0.00% |
IRS | 0.15% | $1.15B | +40.01% | 10.98% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TPMN | -19.92% | $31.54M | 0.65% |
TAIL | -18.29% | $140.49M | 0.59% |
CANE | -16.20% | $10.71M | 0.29% |
VIXY | -14.62% | $109.64M | 0.85% |
CLIP | -14.04% | $1.50B | 0.07% |
ULST | -11.12% | $637.77M | 0.2% |
SHYM | -9.33% | $322.93M | 0.35% |
USDU | -8.87% | $173.44M | 0.5% |
UGA | -8.69% | $73.47M | 0.97% |
TESL | -8.26% | $30.66M | 1.2% |
FMF | -6.85% | $153.73M | 0.95% |
UUP | -6.61% | $292.27M | 0.77% |
CTA | -6.57% | $1.05B | 0.76% |
BOXX | -6.33% | $6.21B | 0.19% |
DBE | -6.27% | $48.48M | 0.77% |
BNO | -5.92% | $86.13M | 1% |
USL | -5.43% | $41.76M | 0.85% |
USO | -5.22% | $956.18M | 0.6% |
QFLR | -5.19% | $291.57M | 0.89% |
OILK | -5.02% | $63.21M | 0.69% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IHI | 60.01% | $4.64B | 0.4% |
SPLV | 57.16% | $7.90B | 0.25% |
IYK | 56.17% | $1.48B | 0.4% |
XLV | 55.75% | $34.49B | 0.09% |
XLP | 55.20% | $15.53B | 0.09% |
IYH | 54.98% | $2.78B | 0.39% |
IXJ | 54.90% | $3.78B | 0.41% |
FHLC | 54.10% | $2.42B | 0.084% |
KXI | 53.95% | $822.83M | 0.41% |
VHT | 53.83% | $14.92B | 0.09% |
VDC | 53.74% | $7.41B | 0.09% |
LVHD | 53.58% | $563.02M | 0.27% |
FSTA | 53.53% | $1.33B | 0.084% |
RSPH | 52.87% | $754.08M | 0.4% |
PPH | 52.22% | $626.20M | 0.36% |
HDV | 51.12% | $10.94B | 0.08% |
LGLV | 50.92% | $1.05B | 0.12% |
SDY | 50.78% | $19.86B | 0.35% |
SPHD | 50.59% | $3.23B | 0.3% |
ACWV | 50.47% | $3.38B | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FTSD | -0.06% | $212.46M | 0.25% |
HIGH | -0.07% | $188.11M | 0.52% |
GCC | -0.07% | $132.18M | 0.55% |
DEFI | 0.09% | $13.07M | 0.94% |
TFLO | 0.14% | $7.06B | 0.15% |
FTXL | 0.20% | $253.66M | 0.6% |
IYW | 0.21% | $19.95B | 0.39% |
IZRL | -0.27% | $105.19M | 0.49% |
SMB | -0.29% | $269.10M | 0.07% |
WTAI | 0.31% | $189.86M | 0.45% |
YMAG | -0.41% | $319.77M | 1.12% |
COM | -0.48% | $222.08M | 0.72% |
CXSE | 0.57% | $414.69M | 0.32% |
VGT | 0.61% | $86.03B | 0.09% |
SMMU | -0.61% | $822.53M | 0.35% |
SGOV | 0.66% | $45.91B | 0.09% |
IXN | 0.75% | $4.88B | 0.41% |
SIVR | 0.77% | $1.68B | 0.3% |
IGPT | 0.77% | $424.44M | 0.58% |
FTEC | 0.81% | $12.93B | 0.084% |
Double maintains 8 strategies that include ABT - Abbott Laboratories